# RADX-TECH- SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1

> **NIH NIH N02** · NOVEL MICRODEVICES, LLC · 2021 · $250,000

## Abstract

We propose to develop a rapid (under 20-minute), point-of-care (PoC) Reverse Transcriptase Loop-mediated Amplification (RT-LAMP) test for the detection of SARS COV-2 virus from human nasal and oral swab and saliva samples. Our SARS-CoV2 RT-LAMP assay will be implemented on our Novel Dx system which comprises an easy-to-use, affordable, ultraportable instrument that performs a fully-automated nucleic acid amplification test (NAAT) on a self-contained, disposable, test-specific cartridge.  Development of this assay will enable SARS CoV-2 testing to be performed in lab-free healthcare settings such as CLIA-waived clinics and physician offices as well as in non-healthcare settings including offices, retail centers, airports and homes. In addition to the development and implementation of a SARS COV-2 RT-LAMP assay on our NovelDx instrument/cartridge system for point-of-care and lab-free settings, the developed LAMP assay will itself be made available for implementation in labs as a mid-to-high throughput SARS-CoV-2 testing solution.  Doing so will greatly increase U.S. capacity for and accessibility to SARS-CoV-2 testing by enabling rapid, highly sensitive and specific isothermal molecular tests to be performed in basic laboratories not otherwise equipped for typical PCR thermocycling-based nucleic acid analyses. Analytical and Clinical Studies on the Novel Dx SARS-CoV-2 test will be performed as per the FDA Emergency Use Authorization (EUA) Guidance, to obtain use authorization. Subsequently we aim to develop a multiplex Flu-A/Flu-B/SARS-CoV-2 assay to detect and differentiate between Influenza and COVID-19 infections. We plan to submit a dual 510(k) and CLIA waiver application for marketing the Novel Dx Flu-A/Flu-B/SARS-CoV-2 test to US healthcare facilities.

## Key facts

- **NIH application ID:** 10505986
- **Project number:** 75N92021P00050-0-0-1
- **Recipient organization:** NOVEL MICRODEVICES, LLC
- **Principal Investigator:** ANDREA PAIS
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $250,000
- **Award type:** —
- **Project period:** 2021-01-19 → 2022-01-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10505986

## Citation

> US National Institutes of Health, RePORTER application 10505986, RADX-TECH- SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 (75N92021P00050-0-0-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10505986. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*